MedGenome to use ₹130-cr funding to raise lab capacity

Swathi Moorthy Chennai | Updated on January 23, 2018

MedGenome, a genomics-based diagnostics and research company, will use the ₹130 crore ($20 million) funding from Sequoia Capital to increase capacity at its research lab in Bengaluru.

It also plans to set up a research lab in the US since transporting samples to India is difficult.

Speaking on the sidelines of a genomics symposium at the Indian Institute of Technology Madras, Sam Santhosh, Chairman, MedGenome, said the company will collaborate with pharmaceutical players in the US for research on new drugs for chronic medical conditions.

Santhosh said pharma companies either approach MedGenome with specific problems or the company approaches pharma players that might be interested in funding research that may benefit them.

Published on August 20, 2015

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor